← Eichor
Study identifier: NCT05748366 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Ultrasound Guided Serratus Anterior Plane Block for Rib Fractures

Condition: Rib Fracture Multiple  ·  Sponsor: WellSpan Health

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is a single center, randomized controlled trial examining the effect of serratus anterior plane block (SAPB) on pain, PIC scores and other clinical outcomes in emergency department patients with multiple rib fractures in comparison to the use of analgesic medication alone. Objectives 1. Compare SAPB performed in the ED setting to analgesic medication alone with regard to pain, respiratory status and PIC score of patients with multiple rib fractures. 2. Assess the safety and feasibility of performing ultrasound-guided SAPB in the ED. 3. Evaluate outcomes of patients receiving the SAPB in the ED including amount of analgesic medications used, level of care required, need for upgrading level of care, and length of stay.

This description comes directly from the study's public registry record.

Talk to the study team

Daniel Kreider, MD  ·  717-851-5817  ·  dkreider3@wellspan.org

Brent Becker, MD  ·  717-851-4819  ·  bbecker2@wellspan.org

Always discuss trial participation with your own doctor first.

Locations (1)

Wellspan Health York HospitalYork, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05748366